Cellebrite DI (CLBT) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Cellebrite’s CEO Yossi Carmil plans to step down by the end of 2024, marking the end of nearly two decades of leadership that saw the company grow significantly in size and market valuation. The company has initiated a search for a new CEO, with Executive Chairman Thomas E. Hogan stepping in as interim CEO. Under Carmil, Cellebrite expanded globally and transitioned to a subscription business model, culminating in a market valuation of approximately $4 billion.
For further insights into CLBT stock, check out TipRanks’ Stock Analysis page.
